Mycronic (OM:MYCR) Stock Faces Margin Drop To 19.9% That Tests Growth Narrative

Mycronic (OM:MYCR) has put fresh numbers on the table for Q2 2026, with Q1 2026 revenue at SEK2.5 billion and basic EPS of SEK3.66, setting the tone for how investors assess the latest run of results. Over recent quarters, the company has seen revenue range from SEK1.7 billion to SEK2.5 billion while basic EPS moved between SEK1.11 and SEK3.66, providing a series of data points for tracking how the earnings profile is evolving. With trailing net margins at 19.9% and market expectations focused on revenue and earnings growth, this update keeps attention firmly on how sustainably Mycronic can defend and potentially rebuild profitability.

See our full analysis for Mycronic.

With the headline figures set, the next step is to see how these results line up with the widely followed narratives around Mycronic’s growth, risks, and profitability, and where the numbers start to challenge those stories.

See what the community is saying about Mycronic

Margins Step Down From 24.2% To 19.9%

• Over the trailing 12 months, Mycronic’s net profit margin stands at 19.9%, compared with 24.2% a year earlier, while trailing revenue is SEK8.3b and net income SEK1.7b.
• Consensus narrative highlights higher R&D and acquisition spending as a way to build future products, and the current margin profile shows the trade off clearly:
  • R&D costs are described as being up SEK60 million year on year, alongside several acquisitions in Global Technologies and Pattern Generators. This lines up with a lower margin even though trailing net income is SEK1.7b on SEK8.3b of revenue.
  • At the same time, analysts still expect revenue to grow around 10.6% a year with margins easing to 17.8%. The recent step down from 24.2% to 19.9% is therefore treated as part of their balanced view rather than ignored.

Premium P/E Versus 40x And DCF Fair Value

• The shares trade on a 40x P/E, compared with 21.9x for the European Electronic industry and 25.8x for peers, and the current price of SEK339.20 sits above an indicated DCF fair value of about SEK314.86.
• Consensus narrative points to growth expectations as the reason some investors accept this premium, yet the numbers introduce clear tension:
  • Analysts’ central case assumes earnings reach SEK2.0b by around 2029 with the stock on a 31.1x multiple. This is lower than today’s 40x and below the current price relative to the DCF fair value of SEK314.86.
  • With the current price of SEK339.20 higher than both the DCF fair value and the single allowed analyst target reference of SEK277.00, the valuation picture asks you to weigh that projected growth against a starting point that is already above these reference levels.

10.3% Revenue Growth Outlook Versus Backlog And Order Cycles

• Forecasts in the dataset point to revenue growth of about 10.3% per year and earnings growth of roughly 12.9% per year, measured against trailing revenue of SEK8.3b and net income of SEK1.7b.
• Bulls argue that long term demand in advanced displays, semiconductors and AI or data center related PCB testing should support that growth, but the bearish narrative flags how uneven orders can still affect the path:
  • On the bullish side, commentary highlights a Pattern Generators backlog of SEK2.3b and recurring aftermarket net sales of SEK465 million as foundations for ongoing revenue. This sits comfortably next to the 10.3% revenue growth forecast.
  • On the bearish side, critics point out a quarter with no new Pattern Generators system orders and an 84% drop in that division’s order intake to SEK191 million, showing how a strong backlog and healthy growth forecast can coexist with lumpy equipment demand that matters for how steadily those forecasts are met.

Bulls wondering how far this growth story can stretch at a premium valuation can see how the order book, margin trend and analyst expectations line up in the full bullish narrative 🐂 Mycronic Bull Case Skeptical readers can test the concerns about order lumpiness, acquisitions and premium multiples against the detailed cautious case in the dedicated bearish narrative 🐻 Mycronic Bear Case

Next Steps

To see how these results tie into long-term growth, risks, and valuation, check out the full range of community narratives for Mycronic on Simply Wall St. Add the company to your watchlist or portfolio so you'll be alerted when the story evolves.

Unsure where you stand after weighing both the bullish and bearish angles on Mycronic? Review the complete set of figures and make your own call, then round out your view with 1 key reward and 1 important warning sign

Explore Alternatives Beyond Mycronic

Mycronic combines a lower net margin of 19.9% with a premium 40x P/E and a share price above both DCF fair value and the single analyst target.

If you are questioning whether that premium starting point leaves enough room for comfort, compare this setup with other ideas using the 213 high quality undervalued stocks.

This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.

Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team@simplywallst.com